Zebra Capital Management LLC Ironwood Pharmaceuticals Inc Transaction History

Zebra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$10.61 - $12.88 $249,716 - $303,143	-23,536 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$10.86 - $13.95 $94,221 - $121,030	-8,676 Reduced 26.93%	23,536 $274,000
Q3 2021 Nov 15, 2021	SELL	$11.92 - $13.92 $252,072 - $294,366	-21,147 Reduced 39.63%	32,212 $421,000
Q2 2021 Aug 16, 2021	SELL	$10.16 - $13.11 $58,552 - $75,552	-5,763 Reduced 9.75%	53,359 $687,000
Q1 2021 May 17, 2021	BUY	$9.04 - $11.86 $534,462 - $701,186	59,122 New	59,122 $661,000

237

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $616M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Zebra Capital Management LLC with notifications on news.